The agreement, which was announced today, to take a majority stake in Mappel, should reinforce the leadership of Ileos in the manufacture of unit-doses and samples for the cosmetics industry through Bioplan, the subsidiary managed by Ludovic Anceau..
Established in 1970 by Marion Appel, the Mappel company is specializing in the manufacture and filling of unit-doses and samples. Brazilian market leader in its field, the company has 230 employees on two production sites in Sao Paolo. According to Ileos, Mappel posted a turnover of 25 million euros in 2010, with strong continued growth.
Managed by Philippe Gelblat, Ileos currently employs 4000 people in 14 locations in Europe, the United States and China. In 2010, the group recorded a turnover of 275 million euros.
After this integration, Ileos “will achieve a turnover of 300 million euros, thus confirming its position as global leader in packaging for the beauty and the healthcare industries,” said the company in release. This operation will also allow the group to expand its international influence in a geographical area with huge potential.
This acquisition fits with the strategy implemented for several years now by the Ileos’ management, which aims to support its key customers through the strengthening of the group’s its position in high growth areas.
"Mappel offers us the opportunity to develop our know-how and serve our customers in Brazil which has such great potential,” commented Philippe Gelblat, President of Ileos, adding that Marion Appel would continue to lead the company.
For its part, the President of Mappel sees in this partnership a “significant potential for Innovation and Industrial synergies".